Ignite Creation Date:
2025-12-24 @ 6:45 PM
Ignite Modification Date:
2026-04-05 @ 7:31 AM
Study NCT ID:
NCT05526157
Status:
COMPLETED
Last Update Posted:
2024-10-15
First Post:
2022-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-19
First Submit QC Date:
None
Study First Post Date:
2022-09-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-10-15
Last Update Post Date Type:
ACTUAL